KR20140058691A - 1,3-부탄디올을 생산하기 위한 진핵 유기체 및 방법 - Google Patents
1,3-부탄디올을 생산하기 위한 진핵 유기체 및 방법 Download PDFInfo
- Publication number
- KR20140058691A KR20140058691A KR1020147009246A KR20147009246A KR20140058691A KR 20140058691 A KR20140058691 A KR 20140058691A KR 1020147009246 A KR1020147009246 A KR 1020147009246A KR 20147009246 A KR20147009246 A KR 20147009246A KR 20140058691 A KR20140058691 A KR 20140058691A
- Authority
- KR
- South Korea
- Prior art keywords
- coa
- acetyl
- bdo
- pathway
- pathway comprises
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 238000000034 method Methods 0.000 title claims abstract description 77
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 title claims abstract description 26
- ZSLZBFCDCINBPY-ZSJPKINUSA-N acetyl-CoA Chemical compound O[C@@H]1[C@H](OP(O)(O)=O)[C@@H](COP(O)(=O)OP(O)(=O)OCC(C)(C)[C@@H](O)C(=O)NCCC(=O)NCCSC(=O)C)O[C@H]1N1C2=NC=NC(N)=C2N=C1 ZSLZBFCDCINBPY-ZSJPKINUSA-N 0.000 claims abstract description 1473
- 230000037361 pathway Effects 0.000 claims abstract description 916
- AXPZIVKEZRHGAS-UHFFFAOYSA-N 3-benzyl-5-[(2-nitrophenoxy)methyl]oxolan-2-one Chemical compound [O-][N+](=O)C1=CC=CC=C1OCC1OC(=O)C(CC=2C=CC=CC=2)C1 AXPZIVKEZRHGAS-UHFFFAOYSA-N 0.000 claims abstract description 569
- 230000001086 cytosolic effect Effects 0.000 claims abstract description 106
- 102000004190 Enzymes Human genes 0.000 claims description 370
- 108090000790 Enzymes Proteins 0.000 claims description 370
- 150000007523 nucleic acids Chemical class 0.000 claims description 249
- 102000039446 nucleic acids Human genes 0.000 claims description 246
- 108020004707 nucleic acids Proteins 0.000 claims description 246
- 102000004316 Oxidoreductases Human genes 0.000 claims description 150
- 108090000854 Oxidoreductases Proteins 0.000 claims description 150
- 102000004357 Transferases Human genes 0.000 claims description 131
- 108090000992 Transferases Proteins 0.000 claims description 123
- 101710088194 Dehydrogenase Proteins 0.000 claims description 108
- 229960001009 acetylcarnitine Drugs 0.000 claims description 102
- KHPXUQMNIQBQEV-UHFFFAOYSA-N oxaloacetic acid Chemical compound OC(=O)CC(=O)C(O)=O KHPXUQMNIQBQEV-UHFFFAOYSA-N 0.000 claims description 102
- 230000002438 mitochondrial effect Effects 0.000 claims description 98
- 108010078791 Carrier Proteins Proteins 0.000 claims description 79
- 230000015572 biosynthetic process Effects 0.000 claims description 72
- 229920001791 ((R)-3-Hydroxybutanoyl)(n-2) Polymers 0.000 claims description 71
- 210000002824 peroxisome Anatomy 0.000 claims description 71
- HSJKGGMUJITCBW-UHFFFAOYSA-N 3-hydroxybutanal Chemical compound CC(O)CC=O HSJKGGMUJITCBW-UHFFFAOYSA-N 0.000 claims description 70
- LCTONWCANYUPML-UHFFFAOYSA-M Pyruvate Chemical compound CC(=O)C([O-])=O LCTONWCANYUPML-UHFFFAOYSA-M 0.000 claims description 70
- KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 claims description 69
- 210000000172 cytosol Anatomy 0.000 claims description 64
- 230000001419 dependent effect Effects 0.000 claims description 64
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 63
- 108090000623 proteins and genes Proteins 0.000 claims description 56
- 230000000593 degrading effect Effects 0.000 claims description 54
- 108010081577 aldehyde dehydrogenase (NAD(P)+) Proteins 0.000 claims description 51
- 230000000694 effects Effects 0.000 claims description 51
- QHHKKMYHDBRONY-RMNRSTNRSA-N 3-hydroxybutanoyl-CoA Chemical compound O[C@@H]1[C@H](OP(O)(O)=O)[C@@H](COP(O)(=O)OP(O)(=O)OCC(C)(C)[C@@H](O)C(=O)NCCC(=O)NCCSC(=O)CC(O)C)O[C@H]1N1C2=NC=NC(N)=C2N=C1 QHHKKMYHDBRONY-RMNRSTNRSA-N 0.000 claims description 48
- RDHQFKQIGNGIED-MRVPVSSYSA-N O-acetyl-L-carnitine Chemical compound CC(=O)O[C@H](CC([O-])=O)C[N+](C)(C)C RDHQFKQIGNGIED-MRVPVSSYSA-N 0.000 claims description 46
- 108010026217 Malate Dehydrogenase Proteins 0.000 claims description 44
- 102000013460 Malate Dehydrogenase Human genes 0.000 claims description 44
- 229930027945 nicotinamide-adenine dinucleotide Natural products 0.000 claims description 43
- XJLXINKUBYWONI-DQQFMEOOSA-N [[(2r,3r,4r,5r)-5-(6-aminopurin-9-yl)-3-hydroxy-4-phosphonooxyoxolan-2-yl]methoxy-hydroxyphosphoryl] [(2s,3r,4s,5s)-5-(3-carbamoylpyridin-1-ium-1-yl)-3,4-dihydroxyoxolan-2-yl]methyl phosphate Chemical compound NC(=O)C1=CC=C[N+]([C@@H]2[C@H]([C@@H](O)[C@H](COP([O-])(=O)OP(O)(=O)OC[C@@H]3[C@H]([C@@H](OP(O)(O)=O)[C@@H](O3)N3C4=NC=NC(N)=C4N=C3)O)O2)O)=C1 XJLXINKUBYWONI-DQQFMEOOSA-N 0.000 claims description 41
- 108091000039 acetoacetyl-CoA reductase Proteins 0.000 claims description 41
- 210000003470 mitochondria Anatomy 0.000 claims description 41
- 150000001299 aldehydes Chemical class 0.000 claims description 38
- 229940049920 malate Drugs 0.000 claims description 37
- IKHGUXGNUITLKF-UHFFFAOYSA-N Acetaldehyde Chemical compound CC=O IKHGUXGNUITLKF-UHFFFAOYSA-N 0.000 claims description 36
- 108030004530 Malonate-semialdehyde dehydrogenases Proteins 0.000 claims description 36
- 108010011939 Pyruvate Decarboxylase Proteins 0.000 claims description 35
- 108010042687 Pyruvate Oxidase Proteins 0.000 claims description 35
- PKQIDSVLSKFZQC-UHFFFAOYSA-N 3-oxobutanal Chemical compound CC(=O)CC=O PKQIDSVLSKFZQC-UHFFFAOYSA-N 0.000 claims description 34
- WDJHALXBUFZDSR-UHFFFAOYSA-M acetoacetate Chemical compound CC(=O)CC([O-])=O WDJHALXBUFZDSR-UHFFFAOYSA-M 0.000 claims description 34
- 230000009467 reduction Effects 0.000 claims description 34
- 238000004519 manufacturing process Methods 0.000 claims description 33
- OJFDKHTZOUZBOS-CITAKDKDSA-N acetoacetyl-CoA Chemical compound O[C@@H]1[C@H](OP(O)(O)=O)[C@@H](COP(O)(=O)OP(O)(=O)OCC(C)(C)[C@@H](O)C(=O)NCCC(=O)NCCSC(=O)CC(=O)C)O[C@H]1N1C2=NC=NC(N)=C2N=C1 OJFDKHTZOUZBOS-CITAKDKDSA-N 0.000 claims description 32
- 108700023175 Phosphate acetyltransferases Proteins 0.000 claims description 31
- 108010092060 Acetate kinase Proteins 0.000 claims description 29
- 108010049926 Acetate-CoA ligase Proteins 0.000 claims description 29
- 108010016219 Acetyl-CoA carboxylase Proteins 0.000 claims description 29
- 102000000452 Acetyl-CoA carboxylase Human genes 0.000 claims description 29
- 102100035709 Acetyl-coenzyme A synthetase, cytoplasmic Human genes 0.000 claims description 29
- 108010018763 Biotin carboxylase Proteins 0.000 claims description 29
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 claims description 28
- 102100022523 Acetoacetyl-CoA synthetase Human genes 0.000 claims description 28
- 108010012842 acetoacetyl-CoA synthetase Proteins 0.000 claims description 28
- WHBMMWSBFZVSSR-UHFFFAOYSA-M 3-hydroxybutyrate Chemical compound CC(O)CC([O-])=O WHBMMWSBFZVSSR-UHFFFAOYSA-M 0.000 claims description 27
- WHBMMWSBFZVSSR-UHFFFAOYSA-N R3HBA Natural products CC(O)CC(O)=O WHBMMWSBFZVSSR-UHFFFAOYSA-N 0.000 claims description 27
- 108010006229 Acetyl-CoA C-acetyltransferase Proteins 0.000 claims description 26
- 108010017192 4-hydroxy-4-methyl-2-oxoglutarate aldolase Proteins 0.000 claims description 24
- 102100029589 Acylpyruvase FAHD1, mitochondrial Human genes 0.000 claims description 24
- 101000694051 Allium cepa Phosphoenolpyruvate phosphatase Proteins 0.000 claims description 24
- 108010081805 Malonyl-CoA decarboxylase Proteins 0.000 claims description 24
- 102100029461 Malonyl-CoA decarboxylase, mitochondrial Human genes 0.000 claims description 24
- 108010069823 Oxaloacetate decarboxylase Proteins 0.000 claims description 24
- 102000013009 Pyruvate Kinase Human genes 0.000 claims description 24
- LIPOUNRJVLNBCD-UHFFFAOYSA-N acetyl dihydrogen phosphate Chemical compound CC(=O)OP(O)(O)=O LIPOUNRJVLNBCD-UHFFFAOYSA-N 0.000 claims description 24
- 108010022074 acetoacetyl-CoA hydrolase Proteins 0.000 claims description 23
- 230000010933 acylation Effects 0.000 claims description 23
- 238000005917 acylation reaction Methods 0.000 claims description 23
- 102000003960 Ligases Human genes 0.000 claims description 22
- 108090000364 Ligases Proteins 0.000 claims description 22
- 150000002576 ketones Chemical class 0.000 claims description 22
- 101710182361 Pyruvate:ferredoxin oxidoreductase Proteins 0.000 claims description 21
- CNNRFBWVTKFGRE-UHFFFAOYSA-N formic acid;2-oxopropanoic acid Chemical compound OC=O.CC(=O)C(O)=O CNNRFBWVTKFGRE-UHFFFAOYSA-N 0.000 claims description 21
- 102000004169 proteins and genes Human genes 0.000 claims description 21
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 claims description 21
- 102000004157 Hydrolases Human genes 0.000 claims description 20
- 108090000604 Hydrolases Proteins 0.000 claims description 20
- 108090000472 Phosphoenolpyruvate carboxykinase (ATP) Proteins 0.000 claims description 20
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 claims description 20
- 108010058912 Acyl-Carrier Protein S-Malonyltransferase Proteins 0.000 claims description 19
- 102100026665 Malonate-CoA ligase ACSF3, mitochondrial Human genes 0.000 claims description 19
- 108010053763 Pyruvate Carboxylase Proteins 0.000 claims description 19
- 102100039895 Pyruvate carboxylase, mitochondrial Human genes 0.000 claims description 19
- 108010075600 citrate-binding transport protein Proteins 0.000 claims description 19
- 108010089734 malonyl-CoA synthetase Proteins 0.000 claims description 19
- 238000012258 culturing Methods 0.000 claims description 18
- 108010008386 malonyl-Coa reductase Proteins 0.000 claims description 18
- 230000032258 transport Effects 0.000 claims description 18
- 108010030844 2-methylcitrate synthase Proteins 0.000 claims description 16
- 108010071536 Citrate (Si)-synthase Proteins 0.000 claims description 16
- 102000006732 Citrate synthase Human genes 0.000 claims description 16
- 102000002667 Glycine hydroxymethyltransferase Human genes 0.000 claims description 16
- 108010043428 Glycine hydroxymethyltransferase Proteins 0.000 claims description 16
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 15
- 230000002238 attenuated effect Effects 0.000 claims description 14
- BOPGDPNILDQYTO-NNYOXOHSSA-N nicotinamide-adenine dinucleotide Chemical compound C1=CCC(C(=O)N)=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OC[C@@H]2[C@H]([C@@H](O)[C@@H](O2)N2C3=NC=NC(N)=C3N=C2)O)O1 BOPGDPNILDQYTO-NNYOXOHSSA-N 0.000 claims description 14
- 108090000124 3-hydroxybutyrate dehydrogenases Proteins 0.000 claims description 13
- 102000034279 3-hydroxybutyrate dehydrogenases Human genes 0.000 claims description 13
- LVSQXDHWDCMMRJ-UHFFFAOYSA-N 4-hydroxybutan-2-one Chemical compound CC(=O)CCO LVSQXDHWDCMMRJ-UHFFFAOYSA-N 0.000 claims description 11
- 108010010870 pyruvate kinase phosphatase Proteins 0.000 claims description 11
- 230000001965 increasing effect Effects 0.000 claims description 10
- 230000002503 metabolic effect Effects 0.000 claims description 10
- 230000006378 damage Effects 0.000 claims description 9
- 108010029731 6-phosphogluconolactonase Proteins 0.000 claims description 8
- 108091000080 Phosphotransferase Proteins 0.000 claims description 8
- 102000020233 phosphotransferase Human genes 0.000 claims description 8
- AWUCVROLDVIAJX-GSVOUGTGSA-N sn-glycerol 3-phosphate Chemical compound OC[C@@H](O)COP(O)(O)=O AWUCVROLDVIAJX-GSVOUGTGSA-N 0.000 claims description 8
- 101000885789 Mycobacterium tuberculosis (strain ATCC 25618 / H37Rv) D-glycerol 3-phosphate phosphatase Proteins 0.000 claims description 7
- 102000006746 NADH Dehydrogenase Human genes 0.000 claims description 7
- -1 acetoacetyl-CoA thiolates Chemical class 0.000 claims description 7
- 239000006227 byproduct Substances 0.000 claims description 7
- 102100031126 6-phosphogluconolactonase Human genes 0.000 claims description 6
- 108050008072 Cytochrome c oxidase subunit IV Proteins 0.000 claims description 6
- 102000000634 Cytochrome c oxidase subunit IV Human genes 0.000 claims description 6
- LXJXRIRHZLFYRP-VKHMYHEASA-N D-glyceraldehyde 3-phosphate Chemical class O=C[C@H](O)COP(O)(O)=O LXJXRIRHZLFYRP-VKHMYHEASA-N 0.000 claims description 6
- 108090000698 Formate Dehydrogenases Proteins 0.000 claims description 6
- 108010086428 NADH Dehydrogenase Proteins 0.000 claims description 6
- 102000001253 Protein Kinase Human genes 0.000 claims description 6
- 210000004027 cell Anatomy 0.000 claims description 6
- 230000037430 deletion Effects 0.000 claims description 6
- 238000012217 deletion Methods 0.000 claims description 6
- 102000006602 glyceraldehyde-3-phosphate dehydrogenase Human genes 0.000 claims description 6
- 108020004445 glyceraldehyde-3-phosphate dehydrogenase Proteins 0.000 claims description 6
- 101710113670 Anaerobic glycerol-3-phosphate dehydrogenase subunit A Proteins 0.000 claims description 5
- 108010074122 Ferredoxins Proteins 0.000 claims description 5
- 239000012528 membrane Substances 0.000 claims description 5
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 4
- 108010018962 Glucosephosphate Dehydrogenase Proteins 0.000 claims description 4
- 239000008103 glucose Substances 0.000 claims description 4
- 239000001963 growth medium Substances 0.000 claims description 4
- 229910052739 hydrogen Inorganic materials 0.000 claims description 4
- 239000001257 hydrogen Substances 0.000 claims description 4
- 101710113668 Anaerobic glycerol-3-phosphate dehydrogenase subunit C Proteins 0.000 claims description 3
- 101710083609 Formate dehydrogenase Proteins 0.000 claims description 3
- 101710165756 Formate dehydrogenase 1 Proteins 0.000 claims description 3
- 101710100740 Formate dehydrogenase, mitochondrial Proteins 0.000 claims description 3
- 230000002068 genetic effect Effects 0.000 claims description 3
- 230000004108 pentose phosphate pathway Effects 0.000 claims description 3
- 238000012546 transfer Methods 0.000 claims description 3
- 102000004567 6-phosphogluconate dehydrogenase Human genes 0.000 claims description 2
- 108020001657 6-phosphogluconate dehydrogenase Proteins 0.000 claims description 2
- 108010068561 Fructose-Bisphosphate Aldolase Proteins 0.000 claims description 2
- 102000001390 Fructose-Bisphosphate Aldolase Human genes 0.000 claims description 2
- 229910019142 PO4 Inorganic materials 0.000 claims description 2
- 238000006114 decarboxylation reaction Methods 0.000 claims description 2
- 230000005565 malate-aspartate shuttle Effects 0.000 claims description 2
- 239000010452 phosphate Substances 0.000 claims description 2
- 108010022393 phosphogluconate dehydratase Proteins 0.000 claims description 2
- 102100037768 Acetyl-CoA acetyltransferase, mitochondrial Human genes 0.000 claims 9
- RXKJFZQQPQGTFL-UHFFFAOYSA-N dihydroxyacetone Chemical compound OCC(=O)CO RXKJFZQQPQGTFL-UHFFFAOYSA-N 0.000 claims 2
- 230000004907 flux Effects 0.000 claims 2
- 230000004077 genetic alteration Effects 0.000 claims 2
- 231100000118 genetic alteration Toxicity 0.000 claims 2
- 125000004435 hydrogen atom Chemical class [H]* 0.000 claims 2
- BJEPYKJPYRNKOW-UHFFFAOYSA-L malate(2-) Chemical compound [O-]C(=O)C(O)CC([O-])=O BJEPYKJPYRNKOW-UHFFFAOYSA-L 0.000 claims 2
- OVHNSJDAZWWTLD-UHFFFAOYSA-N C(CCCCCCCCC)(=O)O.C(C(=O)C)(=O)O Chemical compound C(CCCCCCCCC)(=O)O.C(C(=O)C)(=O)O OVHNSJDAZWWTLD-UHFFFAOYSA-N 0.000 claims 1
- 108010051679 Methylmalonyl-CoA carboxytransferase Proteins 0.000 claims 1
- 229940120503 dihydroxyacetone Drugs 0.000 claims 1
- 230000002255 enzymatic effect Effects 0.000 claims 1
- 210000003527 eukaryotic cell Anatomy 0.000 claims 1
- 239000008194 pharmaceutical composition Substances 0.000 claims 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 claims 1
- 230000003313 weakening effect Effects 0.000 claims 1
- 229940088598 enzyme Drugs 0.000 description 285
- BJEPYKJPYRNKOW-UHFFFAOYSA-N malic acid Chemical compound OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 37
- 206010057190 Respiratory tract infections Diseases 0.000 description 31
- DTBNBXWJWCWCIK-UHFFFAOYSA-K phosphonatoenolpyruvate Chemical compound [O-]C(=O)C(=C)OP([O-])([O-])=O DTBNBXWJWCWCIK-UHFFFAOYSA-K 0.000 description 29
- 229930029653 phosphoenolpyruvate Natural products 0.000 description 25
- LTYOQGRJFJAKNA-KKIMTKSISA-N Malonyl CoA Natural products S(C(=O)CC(=O)O)CCNC(=O)CCNC(=O)[C@@H](O)C(CO[P@](=O)(O[P@](=O)(OC[C@H]1[C@@H](OP(=O)(O)O)[C@@H](O)[C@@H](n2c3ncnc(N)c3nc2)O1)O)O)(C)C LTYOQGRJFJAKNA-KKIMTKSISA-N 0.000 description 23
- LTYOQGRJFJAKNA-DVVLENMVSA-N malonyl-CoA Chemical compound O[C@@H]1[C@H](OP(O)(O)=O)[C@@H](COP(O)(=O)OP(O)(=O)OCC(C)(C)[C@@H](O)C(=O)NCCC(=O)NCCSC(=O)CC(O)=O)O[C@H]1N1C2=NC=NC(N)=C2N=C1 LTYOQGRJFJAKNA-DVVLENMVSA-N 0.000 description 23
- 241000894007 species Species 0.000 description 20
- ZKHQWZAMYRWXGA-KQYNXXCUSA-N Adenosine triphosphate Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)[C@@H](O)[C@H]1O ZKHQWZAMYRWXGA-KQYNXXCUSA-N 0.000 description 17
- 102000005345 Acetyl-CoA C-acetyltransferase Human genes 0.000 description 16
- 101710081616 Citrate/malate transporter Proteins 0.000 description 16
- 230000021736 acetylation Effects 0.000 description 16
- 238000006640 acetylation reaction Methods 0.000 description 16
- OAKURXIZZOAYBC-UHFFFAOYSA-N 3-oxopropanoic acid Chemical compound OC(=O)CC=O OAKURXIZZOAYBC-UHFFFAOYSA-N 0.000 description 15
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 14
- 239000001630 malic acid Substances 0.000 description 14
- 235000011090 malic acid Nutrition 0.000 description 14
- 102000006488 Acyl-Carrier Protein S-Malonyltransferase Human genes 0.000 description 13
- 108020005115 Pyruvate Kinase Proteins 0.000 description 13
- 210000000805 cytoplasm Anatomy 0.000 description 13
- 239000000543 intermediate Substances 0.000 description 13
- 239000000047 product Substances 0.000 description 12
- 235000018102 proteins Nutrition 0.000 description 12
- KAKZBPTYRLMSJV-UHFFFAOYSA-N Butadiene Chemical compound C=CC=C KAKZBPTYRLMSJV-UHFFFAOYSA-N 0.000 description 10
- 238000006243 chemical reaction Methods 0.000 description 10
- 230000006870 function Effects 0.000 description 10
- OFOBLEOULBTSOW-UHFFFAOYSA-L Malonate Chemical compound [O-]C(=O)CC([O-])=O OFOBLEOULBTSOW-UHFFFAOYSA-L 0.000 description 9
- 150000001875 compounds Chemical class 0.000 description 9
- 229920001184 polypeptide Polymers 0.000 description 7
- 108090000765 processed proteins & peptides Proteins 0.000 description 7
- 102000004196 processed proteins & peptides Human genes 0.000 description 7
- 108020002908 Epoxide hydrolase Proteins 0.000 description 6
- 125000002777 acetyl group Chemical group [H]C([H])([H])C(*)=O 0.000 description 6
- 230000014509 gene expression Effects 0.000 description 6
- 230000007614 genetic variation Effects 0.000 description 6
- 230000007246 mechanism Effects 0.000 description 6
- 108010068070 phosphoenolpyruvate carboxylase kinase Proteins 0.000 description 6
- 239000000126 substance Substances 0.000 description 6
- 102000005486 Epoxide hydrolase Human genes 0.000 description 5
- 230000004048 modification Effects 0.000 description 5
- 238000012986 modification Methods 0.000 description 5
- 239000013612 plasmid Substances 0.000 description 5
- 238000006467 substitution reaction Methods 0.000 description 5
- 241000206602 Eukaryota Species 0.000 description 4
- 244000005700 microbiome Species 0.000 description 4
- 239000002243 precursor Substances 0.000 description 4
- 102000016387 Pancreatic elastase Human genes 0.000 description 3
- 108010067372 Pancreatic elastase Proteins 0.000 description 3
- 125000003275 alpha amino acid group Chemical group 0.000 description 3
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 3
- 238000004422 calculation algorithm Methods 0.000 description 3
- 210000000349 chromosome Anatomy 0.000 description 3
- 230000007850 degeneration Effects 0.000 description 3
- RAXXELZNTBOGNW-UHFFFAOYSA-N imidazole Natural products C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 description 3
- 239000002609 medium Substances 0.000 description 3
- 210000003463 organelle Anatomy 0.000 description 3
- 229910052760 oxygen Inorganic materials 0.000 description 3
- 239000001301 oxygen Substances 0.000 description 3
- 230000002829 reductive effect Effects 0.000 description 3
- 239000007858 starting material Substances 0.000 description 3
- 230000009466 transformation Effects 0.000 description 3
- QHHKKMYHDBRONY-WZZMXTMRSA-N (R)-3-hydroxybutanoyl-CoA Chemical compound O[C@@H]1[C@H](OP(O)(O)=O)[C@@H](COP(O)(=O)OP(O)(=O)OCC(C)(C)[C@@H](O)C(=O)NCCC(=O)NCCSC(=O)C[C@H](O)C)O[C@H]1N1C2=NC=NC(N)=C2N=C1 QHHKKMYHDBRONY-WZZMXTMRSA-N 0.000 description 2
- PHIQHXFUZVPYII-ZCFIWIBFSA-N (R)-carnitine Chemical compound C[N+](C)(C)C[C@H](O)CC([O-])=O PHIQHXFUZVPYII-ZCFIWIBFSA-N 0.000 description 2
- 102000001762 6-phosphogluconolactonase Human genes 0.000 description 2
- 102000005751 Alcohol Oxidoreductases Human genes 0.000 description 2
- 108010031132 Alcohol Oxidoreductases Proteins 0.000 description 2
- 102000014914 Carrier Proteins Human genes 0.000 description 2
- 241000255581 Drosophila <fruit fly, genus> Species 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- 108060002716 Exonuclease Proteins 0.000 description 2
- AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 description 2
- 102000012479 Serine Proteases Human genes 0.000 description 2
- 108010022999 Serine Proteases Proteins 0.000 description 2
- AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 description 2
- 239000004473 Threonine Substances 0.000 description 2
- 108091023040 Transcription factor Proteins 0.000 description 2
- 102000040945 Transcription factor Human genes 0.000 description 2
- 108020002494 acetyltransferase Proteins 0.000 description 2
- HSFWRNGVRCDJHI-UHFFFAOYSA-N alpha-acetylene Natural products C#C HSFWRNGVRCDJHI-UHFFFAOYSA-N 0.000 description 2
- 230000001851 biosynthetic effect Effects 0.000 description 2
- 229910052799 carbon Inorganic materials 0.000 description 2
- 229960004203 carnitine Drugs 0.000 description 2
- 238000006555 catalytic reaction Methods 0.000 description 2
- XFTRTWQBIOMVPK-UHFFFAOYSA-N citramalic acid Chemical compound OC(=O)C(O)(C)CC(O)=O XFTRTWQBIOMVPK-UHFFFAOYSA-N 0.000 description 2
- 238000010367 cloning Methods 0.000 description 2
- 230000018044 dehydration Effects 0.000 description 2
- 238000006297 dehydration reaction Methods 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 230000018109 developmental process Effects 0.000 description 2
- 125000002534 ethynyl group Chemical group [H]C#C* 0.000 description 2
- 102000013165 exonuclease Human genes 0.000 description 2
- 239000012634 fragment Substances 0.000 description 2
- 150000002431 hydrogen Chemical class 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 230000037353 metabolic pathway Effects 0.000 description 2
- 238000006241 metabolic reaction Methods 0.000 description 2
- 210000001700 mitochondrial membrane Anatomy 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 230000035772 mutation Effects 0.000 description 2
- 230000003647 oxidation Effects 0.000 description 2
- 238000007254 oxidation reaction Methods 0.000 description 2
- 239000003208 petroleum Substances 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 238000002864 sequence alignment Methods 0.000 description 2
- 230000005945 translocation Effects 0.000 description 2
- MYBVIRDVVZXRTH-UHFFFAOYSA-N 2-(3-oxobutanoyl)propanedioic acid Chemical compound C(=O)(O)C(C(=O)O)C(CC(C)=O)=O MYBVIRDVVZXRTH-UHFFFAOYSA-N 0.000 description 1
- MSWZFWKMSRAUBD-IVMDWMLBSA-N 2-amino-2-deoxy-D-glucopyranose Chemical compound N[C@H]1C(O)O[C@H](CO)[C@@H](O)[C@@H]1O MSWZFWKMSRAUBD-IVMDWMLBSA-N 0.000 description 1
- WPAMZTWLKIDIOP-UCORVYFPSA-N 2-keto-3-deoxy-L-galactonic acid Chemical compound OC[C@H](O)[C@@H](O)CC(=O)C(O)=O WPAMZTWLKIDIOP-UCORVYFPSA-N 0.000 description 1
- FERIUCNNQQJTOY-UHFFFAOYSA-M Butyrate Chemical compound CCCC([O-])=O FERIUCNNQQJTOY-UHFFFAOYSA-M 0.000 description 1
- FERIUCNNQQJTOY-UHFFFAOYSA-N Butyric acid Natural products CCCC(O)=O FERIUCNNQQJTOY-UHFFFAOYSA-N 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- RGJOEKWQDUBAIZ-IBOSZNHHSA-N CoASH Chemical group O[C@@H]1[C@H](OP(O)(O)=O)[C@@H](COP(O)(=O)OP(O)(=O)OCC(C)(C)[C@@H](O)C(=O)NCCC(=O)NCCS)O[C@H]1N1C2=NC=NC(N)=C2N=C1 RGJOEKWQDUBAIZ-IBOSZNHHSA-N 0.000 description 1
- 108091026890 Coding region Proteins 0.000 description 1
- 229920000742 Cotton Polymers 0.000 description 1
- 102000007528 DNA Polymerase III Human genes 0.000 description 1
- 108010071146 DNA Polymerase III Proteins 0.000 description 1
- 102000016928 DNA-directed DNA polymerase Human genes 0.000 description 1
- 108010014303 DNA-directed DNA polymerase Proteins 0.000 description 1
- VGGSQFUCUMXWEO-UHFFFAOYSA-N Ethene Chemical compound C=C VGGSQFUCUMXWEO-UHFFFAOYSA-N 0.000 description 1
- 239000005977 Ethylene Substances 0.000 description 1
- 241000282414 Homo sapiens Species 0.000 description 1
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 1
- 102100025357 Lipid-phosphate phosphatase Human genes 0.000 description 1
- 108060001084 Luciferase Proteins 0.000 description 1
- 241000699666 Mus <mouse, genus> Species 0.000 description 1
- 241000204031 Mycoplasma Species 0.000 description 1
- 108091028043 Nucleic acid sequence Proteins 0.000 description 1
- 108091005804 Peptidases Proteins 0.000 description 1
- 102000035195 Peptidases Human genes 0.000 description 1
- 108010051456 Plasminogen Proteins 0.000 description 1
- 102000013566 Plasminogen Human genes 0.000 description 1
- 102000001938 Plasminogen Activators Human genes 0.000 description 1
- 108010001014 Plasminogen Activators Proteins 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- 235000014680 Saccharomyces cerevisiae Nutrition 0.000 description 1
- 238000012300 Sequence Analysis Methods 0.000 description 1
- 102000003978 Tissue Plasminogen Activator Human genes 0.000 description 1
- 108090000373 Tissue Plasminogen Activator Proteins 0.000 description 1
- IKHGUXGNUITLKF-XPULMUKRSA-N acetaldehyde Chemical compound [14CH]([14CH3])=O IKHGUXGNUITLKF-XPULMUKRSA-N 0.000 description 1
- 125000002252 acyl group Chemical group 0.000 description 1
- 238000007792 addition Methods 0.000 description 1
- 229940024606 amino acid Drugs 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 239000003472 antidiabetic agent Substances 0.000 description 1
- 239000012298 atmosphere Substances 0.000 description 1
- MSWZFWKMSRAUBD-UHFFFAOYSA-N beta-D-galactosamine Natural products NC1C(O)OC(CO)C(O)C1O MSWZFWKMSRAUBD-UHFFFAOYSA-N 0.000 description 1
- 230000003851 biochemical process Effects 0.000 description 1
- 238000005842 biochemical reaction Methods 0.000 description 1
- 230000008827 biological function Effects 0.000 description 1
- 239000007833 carbon precursor Substances 0.000 description 1
- 230000029038 carnitine shuttle Effects 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 238000004113 cell culture Methods 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 230000002759 chromosomal effect Effects 0.000 description 1
- 150000001860 citric acid derivatives Chemical class 0.000 description 1
- 230000002860 competitive effect Effects 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- JJCFRYNCJDLXIK-UHFFFAOYSA-N cyproheptadine Chemical compound C1CN(C)CCC1=C1C2=CC=CC=C2C=CC2=CC=CC=C21 JJCFRYNCJDLXIK-UHFFFAOYSA-N 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 238000006073 displacement reaction Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 150000002118 epoxides Chemical class 0.000 description 1
- 230000004136 fatty acid synthesis Effects 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 238000012239 gene modification Methods 0.000 description 1
- 230000005017 genetic modification Effects 0.000 description 1
- 235000013617 genetically modified food Nutrition 0.000 description 1
- 229960002442 glucosamine Drugs 0.000 description 1
- 229930195712 glutamate Natural products 0.000 description 1
- 230000012010 growth Effects 0.000 description 1
- 230000036571 hydration Effects 0.000 description 1
- 238000006703 hydration reaction Methods 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 230000003301 hydrolyzing effect Effects 0.000 description 1
- 229940126904 hypoglycaemic agent Drugs 0.000 description 1
- 230000002779 inactivation Effects 0.000 description 1
- 230000010354 integration Effects 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 239000004816 latex Substances 0.000 description 1
- 229920000126 latex Polymers 0.000 description 1
- 239000004973 liquid crystal related substance Substances 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 230000006680 metabolic alteration Effects 0.000 description 1
- 239000000178 monomer Substances 0.000 description 1
- 239000002773 nucleotide Substances 0.000 description 1
- 125000003729 nucleotide group Chemical group 0.000 description 1
- 238000005457 optimization Methods 0.000 description 1
- 150000002894 organic compounds Chemical class 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 150000002978 peroxides Chemical class 0.000 description 1
- 239000003348 petrochemical agent Substances 0.000 description 1
- 229940127126 plasminogen activator Drugs 0.000 description 1
- 229920001225 polyester resin Polymers 0.000 description 1
- 239000004645 polyester resin Substances 0.000 description 1
- 102000040430 polynucleotide Human genes 0.000 description 1
- 108091033319 polynucleotide Proteins 0.000 description 1
- 239000002157 polynucleotide Substances 0.000 description 1
- 239000004814 polyurethane Substances 0.000 description 1
- 229920005749 polyurethane resin Polymers 0.000 description 1
- 235000019833 protease Nutrition 0.000 description 1
- 108060006633 protein kinase Proteins 0.000 description 1
- 230000017854 proteolysis Effects 0.000 description 1
- 230000001172 regenerating effect Effects 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 229920003051 synthetic elastomer Polymers 0.000 description 1
- 239000005061 synthetic rubber Substances 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 229960000187 tissue plasminogen activator Drugs 0.000 description 1
- 238000000844 transformation Methods 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/52—Genes encoding for enzymes or proenzymes
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G63/00—Macromolecular compounds obtained by reactions forming a carboxylic ester link in the main chain of the macromolecule
- C08G63/02—Polyesters derived from hydroxycarboxylic acids or from polycarboxylic acids and polyhydroxy compounds
- C08G63/12—Polyesters derived from hydroxycarboxylic acids or from polycarboxylic acids and polyhydroxy compounds derived from polycarboxylic acids and polyhydroxy compounds
- C08G63/16—Dicarboxylic acids and dihydroxy compounds
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/14—Fungi; Culture media therefor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/14—Fungi; Culture media therefor
- C12N1/16—Yeasts; Culture media therefor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P19/00—Preparation of compounds containing saccharide radicals
- C12P19/26—Preparation of nitrogen-containing carbohydrates
- C12P19/28—N-glycosides
- C12P19/30—Nucleotides
- C12P19/32—Nucleotides having a condensed ring system containing a six-membered ring having two N-atoms in the same ring, e.g. purine nucleotides, nicotineamide-adenine dinucleotide
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P7/00—Preparation of oxygen-containing organic compounds
- C12P7/02—Preparation of oxygen-containing organic compounds containing a hydroxy group
- C12P7/04—Preparation of oxygen-containing organic compounds containing a hydroxy group acyclic
- C12P7/18—Preparation of oxygen-containing organic compounds containing a hydroxy group acyclic polyhydric
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Biotechnology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Microbiology (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Virology (AREA)
- Mycology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Botany (AREA)
- Plant Pathology (AREA)
- Physics & Mathematics (AREA)
- Biophysics (AREA)
- Polymers & Plastics (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (11)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201161532492P | 2011-09-08 | 2011-09-08 | |
| US61/532,492 | 2011-09-08 | ||
| US201161541951P | 2011-09-30 | 2011-09-30 | |
| US61/541,951 | 2011-09-30 | ||
| US201161558959P | 2011-11-11 | 2011-11-11 | |
| US61/558,959 | 2011-11-11 | ||
| US201261649039P | 2012-05-18 | 2012-05-18 | |
| US61/649,039 | 2012-05-18 | ||
| US201261655355P | 2012-06-04 | 2012-06-04 | |
| US61/655,355 | 2012-06-04 | ||
| PCT/US2012/054152 WO2013036764A1 (en) | 2011-09-08 | 2012-09-07 | Eukaryotic organisms and methods for producing 1,3-butanediol |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| KR20140058691A true KR20140058691A (ko) | 2014-05-14 |
Family
ID=47830417
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| KR1020147009246A Withdrawn KR20140058691A (ko) | 2011-09-08 | 2012-09-07 | 1,3-부탄디올을 생산하기 위한 진핵 유기체 및 방법 |
Country Status (11)
| Country | Link |
|---|---|
| US (2) | US20130066035A1 (enExample) |
| EP (1) | EP2753699A4 (enExample) |
| KR (1) | KR20140058691A (enExample) |
| CN (1) | CN103917651A (enExample) |
| BR (1) | BR112014005352A2 (enExample) |
| CA (1) | CA2848064A1 (enExample) |
| IN (1) | IN2014CN02584A (enExample) |
| MX (1) | MX2014002787A (enExample) |
| PH (1) | PH12014500513A1 (enExample) |
| SG (1) | SG11201400466TA (enExample) |
| WO (1) | WO2013036764A1 (enExample) |
Families Citing this family (37)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8647642B2 (en) | 2008-09-18 | 2014-02-11 | Aviex Technologies, Llc | Live bacterial vaccines resistant to carbon dioxide (CO2), acidic PH and/or osmolarity for viral infection prophylaxis or treatment |
| JPWO2014045781A1 (ja) * | 2012-09-24 | 2016-08-18 | 昭和電工株式会社 | ブタンジオール類の製造方法 |
| WO2014152665A1 (en) | 2013-03-15 | 2014-09-25 | Genomatica, Inc. | Process and systems for obtaining 1,4-butanediol from fermentation broths |
| EP2971021A4 (en) | 2013-03-15 | 2016-12-21 | Genomatica Inc | MICROORGANISMS AND METHOD FOR THE PRODUCTION OF BUTADIENE AND RELATED COMPOUNDS BY FORMATASSIMILATION |
| WO2014198831A1 (en) * | 2013-06-14 | 2014-12-18 | Technical University Of Denmark | Microbial production of 3-hydroxypropionic acid |
| WO2015057154A2 (en) | 2013-10-18 | 2015-04-23 | Biopetrolia Ab | ENGINEERING OF ACETYL-CoA METABOLISM IN YEAST |
| WO2015077752A1 (en) | 2013-11-25 | 2015-05-28 | Genomatica, Inc. | Methods for enhancing microbial production of specific length fatty alcohols in the presence of methanol |
| EP4296364B1 (en) | 2013-12-03 | 2025-12-03 | Genomatica, Inc. | Microorganisms and methods for improving product yields on methanol using acetyl-coa synthesis |
| EP3087174B1 (en) | 2013-12-27 | 2020-05-13 | Genomatica, Inc. | Methods and organisms with increased carbon flux efficiencies |
| CN120624582A (zh) | 2014-09-18 | 2025-09-12 | 基因组股份公司 | 具有提高的能源效率的非天然微生物 |
| MX380426B (es) | 2014-12-12 | 2025-03-12 | Versalis Spa | Proceso para la produccion de 1,3 butadieno a partir de 1,3 butanodiol. |
| RU2701863C2 (ru) | 2015-02-23 | 2019-10-02 | ВЕРСАЛИС С.п.А. | Способ дегидратации кислородсодержащих соединений |
| US10676723B2 (en) | 2015-05-11 | 2020-06-09 | David Gordon Bermudes | Chimeric protein toxins for expression by therapeutic bacteria |
| WO2016196233A1 (en) | 2015-05-30 | 2016-12-08 | Genomatica, Inc. | Vinylisomerase-dehydratases, alkenol dehydratases, linalool dehydratases and/ crotyl alcohol dehydratases and methods for making and using them |
| CN104988162B (zh) * | 2015-06-08 | 2020-03-17 | 天津大学 | 辅因子再生模块在增强次级代谢产物在微生物中合成的应用 |
| CN104988168A (zh) * | 2015-06-08 | 2015-10-21 | 天津大学 | 乙酰辅酶a增强模块在增强7-脱氢胆甾醇在微生物中合成的应用 |
| KR101704212B1 (ko) | 2015-06-12 | 2017-02-08 | 씨제이제일제당 (주) | 젖산을 생산하는 미생물 및 이를 이용한 젖산 제조 방법 |
| US20170009263A1 (en) * | 2015-07-08 | 2017-01-12 | Invista North America S.A.R.L. | Methods and host cells for enhancing production of 1, 3-butanediol |
| CA2992794A1 (en) * | 2015-07-21 | 2017-01-26 | Radhakrishnan Mahadevan | Methods and microorganisms for the production of 1,3-butanediol |
| EP3359655B1 (en) * | 2015-10-06 | 2019-11-20 | DSM IP Assets B.V. | Eukaryotic cell with increased production of fermentation product |
| CN115322261A (zh) | 2015-10-30 | 2022-11-11 | 基因组股份公司 | 甲醇脱氢酶融合蛋白 |
| US11129906B1 (en) | 2016-12-07 | 2021-09-28 | David Gordon Bermudes | Chimeric protein toxins for expression by therapeutic bacteria |
| US11180535B1 (en) | 2016-12-07 | 2021-11-23 | David Gordon Bermudes | Saccharide binding, tumor penetration, and cytotoxic antitumor chimeric peptides from therapeutic bacteria |
| AU2018244459B2 (en) | 2017-03-31 | 2024-09-19 | Genomatica, Inc. | Aldehyde dehydrogenase variants and methods of use |
| WO2018183640A1 (en) | 2017-03-31 | 2018-10-04 | Genomatica, Inc. | 3-hydroxybutyryl-coa dehydrogenase variants and methods of use |
| CN110892073B (zh) * | 2017-07-11 | 2024-03-01 | 安迪苏法国联合股份有限公司 | 增强型代谢物生产酵母 |
| MX2020000369A (es) | 2017-07-13 | 2020-08-17 | Radici Chimica S P A | Metodos biologicos para preparar terpenos. |
| WO2019014309A1 (en) * | 2017-07-13 | 2019-01-17 | Verdezyne (Abc), Llc | BIOLOGICAL METHODS FOR MODIFYING A CELL CARBON FLOW |
| US20210079334A1 (en) | 2018-01-30 | 2021-03-18 | Genomatica, Inc. | Fermentation systems and methods with substantially uniform volumetric uptake rate of a reactive gaseous component |
| CA3103377A1 (en) | 2018-06-26 | 2020-01-02 | Genomatica, Inc. | Engineered microorganisms with g3p---> 3pg enzyme and/or fructose-1,6-bisphosphatase including those having synthetic or enhanced methylotrophy |
| US12227467B2 (en) | 2018-09-21 | 2025-02-18 | Versalis S.P.A. | Process for bio-1,3-butanediol purification from a fermentation broth |
| CN113179645A (zh) | 2018-09-26 | 2021-07-27 | 基因组股份公司 | 醛脱氢酶变体及其使用方法 |
| WO2020077059A1 (en) * | 2018-10-12 | 2020-04-16 | Yield10 Bioscience, Inc. | Genetically engineered plants that express a quinone-utilizing malate dehydrogenase |
| WO2020090017A1 (ja) * | 2018-10-30 | 2020-05-07 | Ｇｒｅｅｎ Ｅａｒｔｈ Ｉｎｓｔｉｔｕｔｅ 株式会社 | １，３－プロパンジオールの製造方法 |
| CN110564662B (zh) * | 2019-09-30 | 2022-03-25 | 南京农业大学 | 一种整合型高效表达乙醛脱氢酶枯草杆菌的构建方法 |
| CN115873881A (zh) * | 2021-09-30 | 2023-03-31 | 北京化工大学 | 一种产1,3-丁二醇的基因工程菌及其应用 |
| CN117701489B (zh) * | 2024-02-05 | 2024-05-10 | 北京绿色康成生物技术有限公司 | 一种提高大肠杆菌生产1,3-丁二醇的方法 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU718791B2 (en) * | 1995-05-18 | 2000-04-20 | University Of Guelph | A method and nucleotide sequence for transforming microorganisms |
| US8956850B2 (en) * | 2008-06-05 | 2015-02-17 | Butamax Advanced Biofuels Llc | Enhanced pyruvate to acetolactate conversion in yeast |
| EP2078092A2 (en) * | 2006-09-28 | 2009-07-15 | Microbia, Inc. | Production of carotenoids in oleaginous yeast and fungi |
| CN102695799A (zh) * | 2009-09-27 | 2012-09-26 | Opx生物工艺学公司 | 用于制备3-羟基丙酸和其它产物的方法 |
| CN109136161A (zh) * | 2009-12-10 | 2019-01-04 | 基因组股份公司 | 合成气或其他气态碳源和甲醇转化为1,3-丁二醇的方法和有机体 |
| US8871488B2 (en) * | 2010-06-18 | 2014-10-28 | Butamax Advanced Biofuels Llc | Recombinant host cells comprising phosphoketolases |
-
2012
- 2012-09-07 SG SG11201400466TA patent/SG11201400466TA/en unknown
- 2012-09-07 CA CA2848064A patent/CA2848064A1/en not_active Abandoned
- 2012-09-07 US US13/607,527 patent/US20130066035A1/en not_active Abandoned
- 2012-09-07 IN IN2584CHN2014 patent/IN2014CN02584A/en unknown
- 2012-09-07 EP EP12829409.7A patent/EP2753699A4/en not_active Withdrawn
- 2012-09-07 BR BR112014005352A patent/BR112014005352A2/pt not_active IP Right Cessation
- 2012-09-07 MX MX2014002787A patent/MX2014002787A/es unknown
- 2012-09-07 CN CN201280054855.1A patent/CN103917651A/zh active Pending
- 2012-09-07 KR KR1020147009246A patent/KR20140058691A/ko not_active Withdrawn
- 2012-09-07 WO PCT/US2012/054152 patent/WO2013036764A1/en not_active Ceased
- 2012-09-07 PH PH1/2014/500513A patent/PH12014500513A1/en unknown
-
2016
- 2016-10-11 US US15/290,895 patent/US20170247709A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| SG11201400466TA (en) | 2014-04-28 |
| CA2848064A1 (en) | 2013-03-14 |
| IN2014CN02584A (enExample) | 2015-08-07 |
| EP2753699A4 (en) | 2015-08-19 |
| AU2012304428B2 (en) | 2016-03-17 |
| CN103917651A (zh) | 2014-07-09 |
| US20170247709A1 (en) | 2017-08-31 |
| BR112014005352A2 (pt) | 2017-03-28 |
| PH12014500513A1 (en) | 2014-05-12 |
| AU2012304428A1 (en) | 2013-05-02 |
| EP2753699A1 (en) | 2014-07-16 |
| WO2013036764A1 (en) | 2013-03-14 |
| US20130066035A1 (en) | 2013-03-14 |
| MX2014002787A (es) | 2014-12-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US11708589B2 (en) | Microorganisms for producing 1,3-butanediol and methods related thereto | |
| KR20140058691A (ko) | 1,3-부탄디올을 생산하기 위한 진핵 유기체 및 방법 | |
| US9284581B2 (en) | Methods and organisms for converting synthesis gas or other gaseous carbon sources and methanol to 1,3-butanediol | |
| KR102302146B1 (ko) | 1,3-부탄다이올 생산 유기체 | |
| US20140322779A1 (en) | Eukaryotic organisms and methods for increasing the availability of cytosolic acetyl-coa, and for the producing 1,3-butanediol | |
| US20230287464A1 (en) | Microorganisms and methods for the production of butadiene using acetyl-coa | |
| US20140363864A1 (en) | Microorganisms and methods for the production of 1,4-cyclohexanedimethanol | |
| TW202208621A (zh) | 用於生產特定長度脂肪醇及相關化合物之微生物及方法 | |
| KR20120068763A (ko) | 아이소프로판올, ｎ-부탄올 및 아이소부탄올 생산 유기체 | |
| WO2012177601A2 (en) | Microorganisms for producing isobutanol and methods related thereto | |
| AU2012304428B9 (en) | Eukaryotic organisms and methods for producing 1,3-butanediol | |
| AU2012321079A1 (en) | Eukaryotic organisms and methods for increasing the availability of cytosolic acetyl-CoA, and for producing 1,3-butanediol | |
| AU2013203770B2 (en) | Eukaryotic organisms and methods for producing 1,3-butanediol | |
| AU2013203166A1 (en) | Microorganisms for producing 1,3-butanediol and methods related thereto | |
| AU2013203764A1 (en) | Eukaryotic organisms and methods for increasing the availability of cytosolic acetyl-coa, and for producing 1,3-butanediol | |
| AU2013202628A1 (en) | Organisms for the production of 1,3-butanediol |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PA0105 | International application |
Patent event date: 20140408 Patent event code: PA01051R01D Comment text: International Patent Application |
|
| PG1501 | Laying open of application | ||
| PC1203 | Withdrawal of no request for examination | ||
| WITN | Application deemed withdrawn, e.g. because no request for examination was filed or no examination fee was paid |